Your session is about to expire
← Back to Search
Mediterranean Diet for Obesity in Pregnancy (MedDiet Trial)
N/A
Waitlist Available
Led By Julio Mateus Nino, MD, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks, 16, 24, 30 and 40
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two healthy diets in pregnant women to see which one is most beneficial. Participants randomly receive either ACOG program or MedDiet. Both diets focus on eating plants, with MedDiet emphasizing olive oil and limiting red meat. Participants get free food and assessments.
Who is the study for?
This trial is for overweight or obese pregnant women in their first trimester, with a BMI of 25.0 kg/m2 or higher. They must be at least 18 years old and speak English or Spanish. Women with multiple pregnancies except those reduced to a singleton are not eligible.
What is being tested?
The study compares two diet programs during pregnancy: the routine ACOG-based dietary advice versus the Mediterranean Diet (MedDiet) program, which emphasizes plant-based foods and olive oil as the main fat source. Participants will receive free food and guidance according to their assigned diet plan.
What are the potential side effects?
Since this trial involves healthy eating programs rather than medications, side effects are minimal but may include changes in digestion due to dietary adjustments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weeks, 16, 24, 30 and 40
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks, 16, 24, 30 and 40
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Diet Adherence Assessment Scores
Secondary study objectives
Cardiometabolic biomarkers - C-reactive protein (CRP) levels
Cardiometabolic biomarkers - glucose level
Cardiometabolic biomarkers - hemoglobin A1C levels
+4 moreOther study objectives
Number of Adverse Pregnancy Outcomes (APO)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mediterranean Diet (MedDiet) ProgramExperimental Treatment1 Intervention
Well-known healthy diet that consists of a large amount of plant-based foods such as fruits, vegetables, beans, and nuts with extra virgin olive oil (EVOO) as the principal source of fat. Dairy, fish, and poultry are consumed in moderation and red meat only eaten occasionally.
Group II: American College of Obstetricians and Gynecologists (ACOG)-based Dietary ProgramActive Control1 Intervention
Routine dietary counseling program
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,390 Previous Clinical Trials
2,546,575 Total Patients Enrolled
1 Trials studying Gestational Weight Gain
12 Patients Enrolled for Gestational Weight Gain
Julio Mateus Nino, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had high blood pressure before getting pregnant.I am able to make my own medical decisions.My primary language is either English or Spanish.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: American College of Obstetricians and Gynecologists (ACOG)-based Dietary Program
- Group 2: Mediterranean Diet (MedDiet) Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger